# India Retina Health Market > India Retina Health Market Research Report: Size, Share, Trend Analysis By Treatment (Drugs, Therapy, Surgery) and By Disease Indication (Age-Related Macular Degeneration, Diabetic Retinopathy, Inherited Retinal Diseases, Retinoblastoma) - Growth Outlook & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 7.02% - **2024:** $ 931.35 Million - **2025:** $ 996.73 Million - **2035:** $ 1,963.5 Million - **Key Players:** Novartis (CH), Regeneron Pharmaceuticals (US), Roche (CH), Bausch Health Companies (CA), Alcon (CH), Santen Pharmaceutical (JP), Hoya Corporation (JP), Carl Zeiss AG (DE) **Report ID:** MRFR/HC/48366-HCR · **Pages:** 200 · **Author:** Vikita Thakur & Garvit Vyas · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/india-retina-health-market-50123 --- ## Market Summary ## **India Retina Health Market Overview** As per MRFR analysis, the India Retina Health Market Size was estimated at 695.67 (USD Million) in 2023. The India Retina Health Market Industry is expected to grow from 900(USD Million) in 2024 to 1,960 (USD Million) by 2035. The India Retina Health Market CAGR (growth rate) is expected to be around 7.332% during the forecast period (2025 - 2035). ### **Key India Retina Health Market Trends Highlighted** A number of important variables are propelling the notable expansion of the India [Retina Health Market](../../../reports/retina-health-market-10913). One of the main causes is the rising incidence of conditions affecting the retina, such as age-related macular degeneration and diabetic retinopathy. The need for efficient retinal treatments is growing since India is one of the nations with a growing number of diabetics. Furthermore, government programs that improve the infrastructure for eye care and raise knowledge of eye health are essential for promoting market expansion. The establishment of nationwide initiatives to combat blindness and eye disorders highlights the dedication to enhancing retinal health care nationwide. There are several opportunities in the Indian retinal health market, especially in the areas of digital healthcare solutions and telemedicine. In India, teleophthalmology can help close access gaps to eye care because of the country's enormous geographic variety and urban-rural split. Both established and up-and-coming companies can gain market share thanks to developments in surgical methods and imaging technology like optical coherence tomography (OCT). Additionally, cooperation between IT firms and healthcare providers can improve patient outcomes and experience overall. The growing significance of early diagnosis and preventative care is highlighted by recent trends in the Indian retinal health market. Health initiatives that emphasise routine eye exams and screening for eye conditions linked to diabetes are becoming more popular. Additionally, patients' access to retinal care is evolving because to the growth of digital health platforms and online consultations. Retinal screenings and treatments will likely become more in demand as public health announcements and education initiatives raise awareness of eye health, propelling the industry forward. This development suggests that retinal health treatments in India have a bright future. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **India Retina Health Market Drivers** #### **Rising Incidence of Diabetic Retinopathy** The increasing prevalence of diabetes in India is a significant driver for the India Retina Health Market Industry. According to the Indian Council of Medical Research, the number of diabetes patients in India is projected to rise to 134 million by 2040, with a notable number experiencing diabetic retinopathy. This condition is expected to affect nearly 30% of individuals with diabetes, highlighting the urgent need for effective retinal health management solutions. Major healthcare organizations like the All India Institute of Medical Sciences are actively researching and developing innovative treatments specifically targeting diabetic retinopathy, thereby enhancing the growth potential of the market. The support from the Indian government in terms of healthcare funding and initiatives for diabetes management further propels this driver, making it fundamental for the India Retina Health Market. #### **Technological Advancements in Ophthalmic Devices** The rapid development and adoption of advanced ophthalmic devices significantly drive growth in the India Retina Health Market Industry. Innovations such as optical coherence tomography and retinal laser treatment have become more widely available, improving diagnosis accuracy and treatment effectiveness. The market benefits from the investments made by established companies like Johnson & Johnson and Novartis, which are focusing on Research and Development for advanced retinal technologies. Furthermore, the Indian government's push for the Make in India initiative encourages local manufacturing of high-tech medical devices, further stimulating market growth. #### **Government Initiatives for Eye Health** Government initiatives aimed at improving eye health and vision care in India play a critical role in driving the India Retina Health Market Industry. Programs launched by the National Programme for Control of Blindness and Visual Impairment aim to eliminate avoidable blindness, focusing specifically on retinal diseases. With the government's commitment to reduce blindness prevalence significantly, the allocation of budgetary resources has increased in recent years, fostering the development and distribution of retinal health services. Awareness campaigns led by organizations like the Vision Alliance are expected to enhance public understanding of retinal diseases, further boosting demand for retinal health products and services. ### **India Retina Health Market Segment Insights** #### **Retina Health Market Treatment Insights** The Treatment segment of the India Retina Health Market plays a vital role in addressing the increasing prevalence of retinal disorders, significantly contributing to the overall market dynamics. With a growing aging population and rising incidence of conditions such as diabetic retinopathy and age-related macular degeneration, the demand for effective treatment options has surged. The India Retina Health Market revenue is heavily influenced by innovative advancements in medical technologies and therapies, which have improved patient outcomes and maintained a positive trajectory of growth. The market segmentation reflects diverse treatment modalities, including Drugs, Therapy, and Surgery, each addressing unique challenges and offering distinct benefits to patients. Drugs are an essential component, focusing on pharmacological interventions that can manage or treat underlying diseases affecting the retina. Advances in drug formulations and delivery systems have enhanced the effectiveness, leading to better patient adherence and outcomes. Therapy options, such as laser treatments and injections, have gained prominence, providing less invasive alternatives that are widely accepted within the healthcare community. The necessity for these therapies is underscored by the increasing awareness and early diagnosis of retinal conditions in India. Surgery remains an indispensable approach for advanced cases; the advancements in surgical techniques and equipment have improved recovery rates significantly, positioning surgery as a preferred choice for specific conditions like retinal detachments. The India Retina Health Market also faces various challenges, including rising healthcare costs and access to treatment in rural areas, yet it simultaneously presents numerous opportunities. Increased government initiatives and funding for healthcare infrastructure, combined with a growing middle-class population willing to invest in healthcare, are expected to fuel the market growth. As awareness around retinal health improves, the market will likely continue to flourish, accommodating the diverse needs for effective treatment across various demographics. Overall, the Treatment segment is positioned as a cornerstone of the India Retina Health Market, with research and development driving innovations that shape its future landscape. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review #### **Retina Health Market Disease Indication Insights** The India Retina Health Market is witnessing significant growth, particularly within the Disease Indication segment, driven by the increasing prevalence of eye-related diseases. Age-Related Macular Degeneration is increasingly becoming a major concern due to the aging population in India, leading to a growing demand for advanced screening and treatment options. Diabetic Retinopathy, as a complication of diabetes, presents a substantial challenge given the rising number of diabetic patients in the country, necessitating effective management and therapies. Inherited Retinal Diseases, while less common, continue to gain attention as awareness around genetic disorders increases, pushing for Research and Development in personalized treatment plans. Retinoblastoma, although a rare childhood cancer, holds significance in early diagnosis and intervention, pushing healthcare providers to focus on pediatric ophthalmology and related innovations. Overall, the segmentation reveals a clear health challenge that necessitates advancements in technology, treatment methodologies, and public health awareness, creating numerous opportunities for market players engaged in the India Retina Health Market. With a robust healthcare infrastructure and increased government initiatives, the market is poised for further expansion in response to these pressing needs. ### **India Retina Health Market Key Players and Competitive Insights** The India Retina Health Market is characterized by a diverse competitive landscape that is continually evolving to address the growing demand for specialized ophthalmic treatments. With advancements in technology and treatment methods, companies operate in a highly competitive space where they must innovate and adapt to meet the needs of healthcare professionals and patients alike. The increasing prevalence of retinal diseases, coupled with rising awareness about eye health, has incentivized both multinational corporations and local players to focus their resources on developing effective solutions. Factors such as regulatory challenges, pricing pressures, and the dynamic nature of healthcare policies contribute to a complex competitive environment that requires constant vigilance and strategic positioning among market participants. Novartis has established a solid presence in the India Retina Health Market by focusing on innovative therapies and products tailored for retinal diseases. The company leverages its extensive research and development capabilities to create groundbreaking treatments that address various eye conditions. Novartis is recognized for its commitment to quality and efficacy, resulting in a strong brand reputation among healthcare providers and patients. Its strategic partnerships with healthcare institutions and ongoing investments in local production facilities contribute to its competitive edge. Novartis also emphasizes education and awareness programs about eye diseases, enhancing its relationships within the Indian medical community while ensuring that patients are informed about their treatment options. Aster DM Healthcare plays a significant role in the India Retina Health Market, focusing on comprehensive patient care through its network of hospitals and clinics. The company offers a range of key services, including ophthalmology consultations, cutting-edge treatments for retinal disorders, and advanced surgical procedures. Aster DM Healthcare is known for its patient-centric approach and the integration of technology in delivering healthcare solutions. Its strategic growth initiatives include mergers and acquisitions that enhance its service offerings and geographic reach within India. By investing in state-of-the-art medical equipment and fostering collaborations with eye specialists, Aster DM Healthcare aims to remain at the forefront of retinal health services. Additionally, the company actively promotes awareness and preventive care to improve the overall eye health landscape in India, reinforcing its market position. #### **Key Companies in the India Retina Health Market Include** - Novartis - Aster DM Healthcare - [Regeneron Pharmaceuticals](https://www.regeneron.com/stories/retina-impact-innovation) - Lupin Pharmaceuticals - Piramal Pharma - Vitreoretinal Society of India - Alcon - Pfizer - Manipal Hospitals - Roche - Dr. Reddy's Laboratories - Sync Vision - Sightsavers - Zydus Cadila - Bayer ### **India Retina Health Market Industry Developments** The India Retina Health Market has seen significant developments recently, particularly with advancements in treatment and technology. In September 2023, Novartis announced the launch of a cutting-edge therapy for retinal diseases in India, aiming to enhance patient outcomes. Aster DM Healthcare has expanded its network of eye hospitals, focusing on comprehensive retina services to address the growing prevalence of retinal disorders in the country. In terms of market growth, Regeneron Pharmaceuticals reported a rise in demand for its retinal medications, indicating a positive trend toward innovative therapies. Moreover, Lupin Pharmaceuticals has made strides in developing affordable treatment options for age-related macular degeneration, contributing to increased accessibility in the region. Meanwhile, the Vitreoretinal Society of India held its annual conference in August 2023, emphasizing the importance of collaborative efforts among medical professionals and researchers. Notably, Pfizer and Roche continue to expand their portfolios concerning retinal health, which is expected to drive competitive dynamics within the market. Furthermore, a report in July 2023 highlighted collaboration initiatives between Sync Vision and Sightsavers focusing on enhanced diagnostics and patient care pathways for retinal diseases in underprivileged populations in India. ### **India Retina Health Market Segmentation Insights** #### **Retina Health Market Treatment Outlook** - Drugs - Therapy - Surgery #### **Retina Health Market Disease Indication Outlook** - Age-Related Macular Degeneration - Diabetic Retinopathy - Inherited Retinal Diseases - Retinoblastoma ## Market Drivers ### Rising Incidence of Diabetes The escalating incidence of diabetes in India is a major driver for the retina health market. With diabetes being a leading cause of diabetic retinopathy, the demand for retinal health services is expected to rise sharply. Current estimates indicate that over 77 million adults in India are living with diabetes, and this number is projected to increase. Consequently, the retina health market is likely to expand as healthcare providers focus on screening and treating diabetic patients to prevent vision loss. This trend may lead to a market growth of approximately 25% over the next decade, as more resources are allocated to managing diabetes-related retinal complications. ### Increasing Awareness of Eye Health The rising awareness regarding eye health in India is a pivotal driver for the retina health market. Campaigns by healthcare organizations and government bodies have significantly contributed to educating the public about the importance of regular eye check-ups. This heightened awareness is likely to lead to an increase in early diagnosis of retinal disorders, which could enhance treatment outcomes. As a result, the demand for retinal health services and products is expected to grow. The retina health market is projected to expand as more individuals seek preventive care and treatment options, potentially increasing market revenues by an estimated 15% over the next five years. ### Advancements in Treatment Modalities Innovations in treatment modalities for retinal disorders are significantly shaping the retina health market. The introduction of novel therapies, such as anti-VEGF injections and gene therapy, has revolutionized the management of various retinal conditions. These advancements not only improve patient outcomes but also expand the range of treatment options available. The market is witnessing a shift towards more effective and less invasive procedures, which could enhance patient compliance and satisfaction. As a result, the retina health market is likely to experience a growth rate of around 18% annually, driven by the increasing adoption of these advanced treatment modalities. ### Investment in Healthcare Infrastructure Investment in healthcare infrastructure in India is a significant driver for the retina health market. The government and private sector are increasingly allocating funds to enhance healthcare facilities, particularly in urban and rural areas. This investment is likely to improve access to eye care services, including specialized retina clinics and advanced diagnostic equipment. As healthcare infrastructure improves, the retina health market is expected to benefit from increased patient footfall and enhanced service delivery. Projections suggest that this investment could lead to a market growth of around 30% in the next five years, as more individuals gain access to essential retinal health services. ### Aging Population and Associated Health Issues India's demographic shift towards an aging population is a crucial factor influencing the retina health market. As the population ages, the prevalence of age-related retinal conditions, such as macular degeneration and diabetic retinopathy, is likely to rise. According to recent statistics, approximately 10% of the elderly population in India suffers from some form of retinal disorder. This trend suggests a growing need for specialized retinal care and treatment options, thereby driving market growth. The retina health market is expected to see a surge in demand for innovative therapies and diagnostic tools tailored to this demographic, potentially increasing market size by 20% in the coming years. ## Future Outlook The [Retina Health Market](https://www.marketresearchfuture.com/reports/retina-health-market-10913) in India is projected to grow at a 7.02% CAGR from 2025 to 2035, driven by technological advancements, increasing prevalence of retinal diseases, and rising healthcare expenditure. **New opportunities:** - Development of AI-driven diagnostic tools for early detection of retinal diseases. - Expansion of telemedicine services for remote retinal consultations. - Investment in advanced surgical equipment for minimally invasive procedures. By 2035, the retina health market is expected to achieve substantial growth and innovation. ## Segment Insights ### By Treatment: Drugs (Largest) vs. Surgery (Fastest-Growing) In the India retina health market, the distribution of market share among the treatment segment values is quite varied. Drugs currently hold the largest share, driven by a wide range of pharmaceutical options available for retinal diseases. Surgery, on the other hand, is gaining traction and is recognized as the fastest-growing area due to technological advancements and increased awareness. Growth trends in this segment point towards a significant increase in the adoption of innovative therapeutic options and surgical techniques. Factors such as an aging population and a rise in diabetic and other retinal conditions are boosting the demand for effective treatments. Additionally, public and private investments in healthcare infrastructure further catalyze the growth of the surgery segment, enhancing access to advanced procedures. Drugs (Dominant) vs. Surgery (Emerging) Drugs represent the dominant segment in the treatment landscape, characterized by a robust pipeline of therapeutics, including anti-VEGF agents and corticosteroids specifically targeting retinal conditions. The availability of generic options also bolsters this segment, making treatments more accessible to patients. Conversely, the surgery segment is emerging rapidly, fueled by innovations like minimally invasive techniques and improved surgical devices. This segment's growth is further supported by an increase in training for ophthalmic surgeons, leading to better patient outcomes and increased surgical volume. Overall, the contrasting dynamics of these segments indicate a diverse treatment approach within the India retina health market. ### By Disease Indication: Age-Related Macular Degeneration (Largest) vs. Diabetic Retinopathy (Fastest-Growing) In the India retina health market, Age-Related Macular Degeneration (AMD) commands the largest market share, attributed to the aging population and rising awareness about retinal diseases. Diabetic Retinopathy (DR) follows closely, benefiting from the increasing prevalence of diabetes and associated retinal complications. Inherited Retinal Diseases and Retinoblastoma present smaller segments but contribute to the diversity of indications driving market strategies. The growth of the segment is bolstered by advancements in diagnostic technologies and innovative treatment options, creating a competitive landscape. The aging demographic is a significant driver for AMD, while the surge in diabetes incidences propels the interest in DR treatments. Moreover, the increased funding in research and development fosters growth across all indications in the market. Age-Related Macular Degeneration (Dominant) vs. Diabetic Retinopathy (Emerging) Age-Related Macular Degeneration (AMD) remains the dominant segment in the India retina health market, primarily impacting the elderly. The condition leads to vision loss and has prompted substantial investment in therapeutic solutions and awareness campaigns. The segment benefits from a well-established understanding among healthcare professionals, allowing for effective diagnosis and management. Conversely, Diabetic Retinopathy is an emerging segment driven by the alarming rise in diabetes cases. With the potential for vision-threatening complications, the focus on early detection and treatment is paramount. This segment is characterized by innovative care delivery models and the integration of technology into treatment protocols, making it a vital area for future growth. ## Competitive Benchmarking The retina health market in India is characterized by a dynamic competitive landscape, driven by increasing prevalence of retinal diseases and a growing aging population. Key players such as Novartis (CH), Regeneron Pharmaceuticals (US), and Roche (CH) are strategically positioned to leverage innovation and expand their market presence. Novartis (CH) focuses on developing advanced therapies for retinal diseases, while Regeneron Pharmaceuticals (US) emphasizes its robust pipeline of ophthalmic treatments. Roche (CH) is also investing heavily in research and development to enhance its product offerings, indicating a collective strategy among these companies to shape a competitive environment centered around innovation and patient-centric solutions.In terms of business tactics, companies are increasingly localizing manufacturing and optimizing supply chains to enhance operational efficiency. The market appears moderately fragmented, with several players vying for market share. However, the collective influence of major companies is significant, as they drive advancements in technology and treatment options, thereby shaping the overall market structure. In October Novartis (CH) announced a partnership with a leading Indian healthcare provider to enhance access to its retinal therapies across the country. This strategic move is likely to improve patient access and strengthen Novartis's market position in India, reflecting a broader trend of companies seeking to establish local partnerships to enhance distribution and service delivery. In September Regeneron Pharmaceuticals (US) launched a new clinical trial for its innovative retinal treatment, which aims to address unmet needs in the market. This initiative underscores Regeneron's commitment to research and development, potentially positioning the company as a leader in the ophthalmic space as it seeks to bring new therapies to market. In August Roche (CH) expanded its manufacturing capabilities in India, focusing on the production of biologics for retinal diseases. This expansion not only enhances Roche's operational capacity but also aligns with the growing demand for advanced therapies in the region, suggesting a strategic focus on meeting local market needs while ensuring supply chain reliability. As of November current competitive trends in the retina health market include a strong emphasis on digitalization, sustainability, and the integration of artificial intelligence (AI) in treatment development. Strategic alliances are increasingly shaping the landscape, as companies collaborate to enhance their technological capabilities and market reach. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on innovation, technology, and the reliability of supply chains, indicating a shift towards more sustainable and patient-centered approaches in the retina health market. ## Recent News & Developments The India Retina Health Market has seen significant developments recently, particularly with advancements in treatment and technology. In September 2023, Novartis announced the launch of a cutting-edge therapy for retinal diseases in India, aiming to enhance patient outcomes. Aster DM Healthcare has expanded its network of eye hospitals, focusing on comprehensive retina services to address the growing prevalence of retinal disorders in the country. In terms of market growth, Regeneron Pharmaceuticals reported a rise in demand for its retinal medications, indicating a positive trend toward innovative therapies. Moreover, Lupin Pharmaceuticals has made strides in developing affordable treatment options for age-related macular degeneration, contributing to increased accessibility in the region. Meanwhile, the Vitreoretinal Society of India held its annual conference in August 2023, emphasizing the importance of collaborative efforts among medical professionals and researchers. Notably, Pfizer and Roche continue to expand their portfolios concerning retinal health, which is expected to drive competitive dynamics within the market. Furthermore, a report in July 2023 highlighted collaboration initiatives between Sync Vision and Sightsavers focusing on enhanced diagnostics and patient care pathways for retinal diseases in underprivileged populations in India. ## Report Scope | MARKET SIZE 2024 | 931.35(USD Million) | | --- | --- | | MARKET SIZE 2025 | 996.73(USD Million) | | MARKET SIZE 2035 | 1963.5(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.02% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Novartis (CH), Regeneron Pharmaceuticals (US), Roche (CH), Bausch Health Companies (CA), Alcon (CH), Santen Pharmaceutical (JP), Hoya Corporation (JP), Carl Zeiss AG (DE) | | Segments Covered | Treatment, Disease Indication | | Key Market Opportunities | Advancements in telemedicine and AI-driven diagnostics enhance accessibility in the retina health market. | | Key Market Dynamics | Rising demand for advanced retinal therapies drives innovation and competition in the retina health market. | | Countries Covered | India | ## Frequently Asked Questions **Q: What was the overall valuation of the India retina health market in 2024?** A: The overall market valuation was $931.35 Million in 2024. **Q: What is the projected market valuation for the India retina health market by 2035?** A: The projected valuation for 2035 is $1963.5 Million. **Q: What is the expected CAGR for the India retina health market during the forecast period 2025 - 2035?** A: The expected CAGR for the market during the forecast period is 7.02%. **Q: Which companies are considered key players in the India retina health market?** A: Key players include Novartis, Regeneron Pharmaceuticals, Roche, Bausch Health Companies, Alcon, Santen Pharmaceutical, Hoya Corporation, and Carl Zeiss AG. **Q: What were the treatment segment valuations for the India retina health market in 2024?** A: In 2024, the treatment segment valuations were $186.27 Million for drugs, $186.27 Million for therapy, and $558.81 Million for surgery. **Q: How does the market for diabetic retinopathy compare to other disease indications in 2024?** A: In 2024, the market for diabetic retinopathy was valued at $279.35 Million, which is higher than inherited retinal diseases and age-related macular degeneration. **Q: What is the projected growth for the surgery segment in the India retina health market by 2035?** A: The surgery segment is projected to grow to $1178.1 Million by 2035. **Q: What were the valuations for age-related macular degeneration in 2024?** A: The valuation for age-related macular degeneration in 2024 was $186.27 Million. **Q: What is the expected trend for the India retina health market in the coming years?** A: The India retina health market is expected to experience robust growth, reaching $1963.5 Million by 2035. **Q: How do the valuations for inherited retinal diseases compare to retinoblastoma in 2024?** A: In 2024, both inherited retinal diseases and retinoblastoma had valuations of $186.27 Million and $279.35 Million, respectively. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/india-retina-health-market-50123*